Cinemark Holdings, Inc. (NYSE:CNK – Free Report) – Research analysts at Barrington Research lowered their Q2 2025 earnings per share estimates for Cinemark in a note issued to investors on Thursday, February 20th. Barrington Research analyst P. Sholl now forecasts that the company will post earnings per share of $0.49 for the quarter, down from their prior estimate of $0.58. Barrington Research currently has a “Outperform” rating and a $40.00 price target on the stock. The consensus estimate for Cinemark’s current full-year earnings is $1.98 per share. Barrington Research also issued estimates for Cinemark’s Q3 2025 earnings at $0.53 EPS, Q1 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.71 EPS and FY2027 earnings at $2.09 EPS.
Cinemark (NYSE:CNK – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.39 by ($0.06). The firm had revenue of $814.30 million for the quarter, compared to analyst estimates of $797.18 million. Cinemark had a return on equity of 65.83% and a net margin of 10.16%. The business’s revenue for the quarter was up 27.5% on a year-over-year basis. During the same period in the previous year, the business posted ($0.15) earnings per share.
View Our Latest Research Report on CNK
Cinemark Trading Down 3.0 %
NYSE CNK opened at $27.72 on Friday. Cinemark has a twelve month low of $15.74 and a twelve month high of $36.28. The company has a quick ratio of 0.96, a current ratio of 0.98 and a debt-to-equity ratio of 3.87. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 13.65 and a beta of 2.38. The business’s fifty day moving average is $30.33 and its 200 day moving average is $29.75.
Cinemark Announces Dividend
The company also recently disclosed a — dividend, which will be paid on Wednesday, March 19th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $0.08 per share. The ex-dividend date is Wednesday, March 5th.
Institutional Investors Weigh In On Cinemark
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mackenzie Financial Corp acquired a new stake in shares of Cinemark during the fourth quarter worth $221,000. Elequin Capital LP increased its holdings in Cinemark by 211.6% in the fourth quarter. Elequin Capital LP now owns 997 shares of the company’s stock valued at $31,000 after buying an additional 677 shares in the last quarter. PharVision Advisers LLC purchased a new stake in Cinemark during the fourth quarter worth $277,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Cinemark by 24.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 319,768 shares of the company’s stock valued at $9,906,000 after acquiring an additional 61,911 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new position in shares of Cinemark during the 4th quarter worth approximately $8,317,000.
Cinemark Company Profile
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
See Also
- Five stocks we like better than Cinemark
- Roth IRA Calculator: Calculate Your Potential Returns
- Palantir Stock Skids—How Much Further Can It Fall?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- Stock Average Calculator
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.